Drug Trial Radar · NCT01687712
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Last checked: Nov 20, 2026Latest source record: Dec 5, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,100
Actual
Start
Nov 25, 2013
Primary completion
Sep 10, 2015
Study completion Nov 14, 2016
Sponsor
- Lead sponsor
- Fertility Biotech AGIndustry
- Sponsor type
- Industry
- First posted
- Sep 19, 2012
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- Female only, from 35 years, up to 42 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to show that AFOLIA, a recombinant manufactured human follicle stimulating hormone (r-hFSH) has a similar efficacy and safety profile compared to Gonal-f® RFF.
Conditions
- Infertility
Interventions
AFOLIADrug
225IU subcutaneously, starting at the day of successful down-regulation for the first 5 days, followed by a treatment period with an increased dose until the point of ovulation induction has been reached
Gonal-f® RFFDrug
225IU subcutaneously, starting at the day of successful down-regulation for the first 5 days, followed by a treatment period with an increased dose until the point of ovulation induction has been reached
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinical Pregnancy Rate After One Cycle of Treatment - ITT PopulationTime frame: Six weeks post embryo transfer
- Clinical Pregnancy Rate After One Cycle of Treatment - PP PopulationTime frame: Six weeks post embryo transfer
Locations
22 sites in 1 country. Site status is shown where the registry gives one.
Physicians Research Group
Tempe, Arizona
HRC Fertility
Encino, California
Reproductive Associates of Delaware
Newark, Delaware
FL Fertility Institution
Tampa, Florida
Georgia Reproductive Specialists
Atlanta, Georgia
Fertility Centers of Illinois
Chicago, Illinois
In Via Fertility Specialists
Hoffman Estate, Illinois
Shady Grove Fertility RSC
Rockville, Maryland
Nevada Center for Reproductive Medicine
Reno, Nevada
Cooper Institute of Reproductive Hormonal Disorders, P.C.
Marlton, New Jersey
Institute for Reproductive Health
Cincinnati, Ohio
Abington Reproductive Medicine
Abington, Pennsylvania
Main Line Fertility Center
Bryn Mawr, Pennsylvania
Shady Grove Fertility RSC, Chesterbrook, PA
Chesterbrook, Pennsylvania
University of Penn
Philadelphia, Pennsylvania
Fertility Associates of Memphis
Memphis, Tennessee
Texas Fertility Center
Austin, Texas
Center for Assisted Reproduction
Bedford, Texas
Fertility Specialists of Houston
Houston, Texas
Houston Fertility Institute
Houston, Texas
Center of Reproducitve Medicine
Webster, Texas
Jones Institute for Reproductive Medicine
Norfolk, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.